data_1iu0_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1iu0 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.511 ' HG3' ' HB3' ' A' ' 91' ' ' ARG . 5.7 ttm . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 120.811 0.339 . . . . 3.5499999999999998 111.292 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.8 137.83 32.1 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.082 -0.508 . . . . 2.5299999999999998 110.61 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.471 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 6.3 m-30 -105.74 122.56 46.32 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.472 -0.331 . . . . 2.3599999999999999 111.025 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -126.94 150.07 49.53 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.26 -0.427 . . . . 2.3900000000000001 111.404 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.03 145.25 30.43 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.109 -0.496 . . . . 2.4500000000000002 110.966 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.471 HD13 ' CD1' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -133.76 109.15 12.77 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 CA-C-O 120.929 0.395 . . . . 1.3999999999999999 111.388 -179.913 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.449 ' CG2' HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -78.26 115.39 17.94 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.092 -0.707 . . . . 1.3999999999999999 109.092 179.065 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.656 HD12 ' HA ' ' A' ' 45' ' ' ALA . 5.4 tp -126.64 126.11 43.02 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 113.01 0.744 . . . . 1.1599999999999999 113.01 -177.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.521 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -83.02 100.23 10.33 Favored 'General case' 0 CA--C 1.523 -0.083 0 CA-C-N 115.775 -0.648 . . . . 1.96 111.719 179.255 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.559 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -52.37 92.29 0.01 OUTLIER 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.566 -0.743 . . . . 2.71 110.546 179.079 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.61 -172.25 3.82 Favored Glycine 0 CA--C 1.52 0.384 0 CA-C-N 115.244 -0.889 . . . . 1.4299999999999999 113.26 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -55.57 -44.91 77.29 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.601 0.239 . . . . 3.6800000000000002 111.151 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 56.3 m -77.45 -25.13 50.29 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.364 -0.38 . . . . 2.23 111.406 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 138.56 -157.59 24.66 Favored Glycine 0 C--N 1.338 0.673 0 C-N-CA 120.99 -0.624 . . . . 0.89000000000000001 112.256 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.582 ' HG ' ' CD2' ' A' ' 8' ' ' LEU . 7.3 tp -67.71 -53.76 24.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.503 0.152 . . . . 1.9399999999999999 110.786 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 119.4 26.29 2.46 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 120.107 -1.044 . . . . 0.63 115.636 177.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.739 ' HB3' HG22 ' A' ' 39' ' ' ILE . 24.8 p90 -164.35 136.29 4.65 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 118.324 1.062 . . . . 2.1600000000000001 110.992 178.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.3 134.8 40.81 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.999 -0.546 . . . . 0.97999999999999998 111.703 -179.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.668 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -117.16 146.32 21.75 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-O 121.699 0.761 . . . . 1.0700000000000001 112.085 179.917 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.629 ' HB3' ' HB2' ' A' ' 27' ' ' HIS . . . -137.8 134.79 35.61 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.34 -1.3 . . . . 1.1799999999999999 111.318 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.425 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 145.37 -6.97 1.53 Allowed Glycine 0 CA--C 1.52 0.357 0 C-N-CA 119.908 -1.139 . . . . 1.8 114.294 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.617 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -57.3 178.21 1.0 Allowed Glycine 0 CA--C 1.521 0.466 0 C-N-CA 120.944 -0.646 . . . . 2.0699999999999998 113.97 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.41 ' N ' ' HA ' ' A' ' 69' ' ' THR . 19.0 p -60.99 -29.33 69.62 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.037 0.754 . . . . 1.3700000000000001 113.037 -178.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.486 ' CB ' ' HB ' ' A' ' 69' ' ' THR . 19.3 t70 -87.57 -33.43 18.9 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 111.909 0.337 . . . . 1.8899999999999999 111.909 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -124.52 88.65 53.11 Favored Pre-proline 0 N--CA 1.453 -0.29 0 CA-C-N 116.663 -0.244 . . . . 2.1099999999999999 110.484 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -69.46 73.2 1.25 Allowed 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.662 2.241 . . . . 1.0900000000000001 112.814 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.721 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 25.7 t60 -52.13 -31.26 30.2 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.529 -0.76 . . . . 2.2999999999999998 110.262 178.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.666 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -79.25 -157.36 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 115.618 -0.719 . . . . 1.3200000000000001 109.965 178.829 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.68 -50.8 60.93 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.752 -0.737 . . . . 1.3899999999999999 112.347 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 177.41 61.32 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.995 0.426 . . . . 2.3500000000000001 110.595 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -148.3 164.61 21.15 Favored Pre-proline 0 C--O 1.234 0.258 0 CA-C-N 116.045 -0.525 . . . . 1.7 111.348 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -78.85 7.68 4.16 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.755 2.303 . . . . 1.27 113.139 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 68.4 m -61.48 109.8 1.28 Allowed 'General case' 0 C--N 1.341 0.228 0 CA-C-O 120.768 0.318 . . . . 1.53 110.412 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.613 HD12 ' HB1' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -81.68 118.92 30.27 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.371 0 CA-C-N 115.817 -0.629 . . . . 1.25 110.609 -179.485 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.721 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -140.28 148.63 41.71 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-O 121.442 0.639 . . . . 2.2400000000000002 110.948 178.543 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.668 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -68.55 156.44 7.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 115.428 -0.805 . . . . 1.03 113.058 -176.885 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.53 HG21 ' HB2' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -121.35 -33.05 3.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.776 -1.102 . . . . 1.1100000000000001 111.629 -179.541 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.684 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.13 136.17 0.83 Allowed 'General case' 0 C--N 1.338 0.085 0 CA-C-O 120.874 0.369 . . . . 1.96 111.712 -179.832 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.739 HG22 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -99.33 130.76 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 108.199 -1.037 . . . . 1.0900000000000001 108.199 177.823 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.447 HD13 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -83.06 118.81 72.86 Favored Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 112.391 0.515 . . . . 1.1599999999999999 112.391 -177.376 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.491 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 32.3 Cg_exo -58.37 134.69 63.04 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 123.186 2.591 . . . . 1.27 112.32 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.37 -5.62 65.27 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 120.895 -0.669 . . . . 1.05 112.79 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -95.82 177.28 34.13 Favored Glycine 0 C--N 1.339 0.722 0 C-N-CA 120.823 -0.703 . . . . 1.1599999999999999 111.732 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.491 ' HB2' ' HG ' ' A' ' 8' ' ' LEU . . . -56.19 -37.34 69.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.887 0.343 . . . . 1.22 111.303 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.656 ' HA ' HD12 ' A' ' 8' ' ' LEU . . . -69.59 -51.69 32.91 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.53 -0.305 . . . . 1.0900000000000001 111.717 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.491 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -67.28 -32.33 73.26 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.272 -0.422 . . . . 1.1599999999999999 111.858 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -73.41 -38.89 65.42 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.715 0.293 . . . . 2.98 110.733 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.43 -58.29 4.18 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.022 -0.536 . . . . 1.8500000000000001 111.043 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.1 35.39 18.34 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.897 -0.592 . . . . 0.67000000000000004 112.588 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 48.1 mtt180 -107.48 -30.24 8.76 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 116.733 0.267 . . . . 3.3799999999999999 110.959 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.548 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 7.3 tp -99.44 155.79 17.37 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.014 0.435 . . . . 1.0800000000000001 111.446 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.548 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.5 OUTLIER -132.15 145.19 51.21 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.577 -0.738 . . . . 3.9900000000000002 110.807 179.947 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.684 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 36.1 t -60.96 154.93 4.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 121.083 0.468 . . . . 1.0900000000000001 111.656 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.443 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 1.3 t-20 77.11 1.08 3.11 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.178 -0.919 . . . . 2.0499999999999998 112.07 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.606 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 0.4 OUTLIER -74.88 127.42 33.15 Favored 'General case' 0 C--N 1.338 0.101 0 N-CA-C 109.37 -0.604 . . . . 1.21 109.37 178.889 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.6 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 1.6 t -84.79 102.08 12.75 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 121.611 0.719 . . . . 1.6299999999999999 111.65 -178.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.533 HD12 HG22 ' A' ' 19' ' ' ILE . 59.0 mt -45.69 136.49 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 114.593 -1.185 . . . . 1.1100000000000001 112.258 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.522 ' HB2' ' HB3' ' A' ' 87' ' ' TYR . 5.1 mt -112.25 -50.29 2.91 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.301 -0.863 . . . . 2.4300000000000002 110.165 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.514 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.7 m-85 -143.45 159.67 41.98 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.775 -0.648 . . . . 2.2200000000000002 111.276 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.454 ' HA ' ' CD2' ' A' ' 86' ' ' LEU . 97.5 t -133.86 93.33 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.616 -0.72 . . . . 1.3899999999999999 109.331 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.552 ' HB2' HG23 ' A' ' 84' ' ' VAL . 2.6 t-20 70.98 -68.84 0.2 Allowed 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 109.593 -0.521 . . . . 1.9299999999999999 109.593 -177.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -153.56 31.17 0.46 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.878 -0.601 . . . . 2.6499999999999999 110.117 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.514 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 6.9 t -121.39 135.67 60.79 Favored 'Isoleucine or valine' 0 C--N 1.339 0.113 0 CA-C-N 116.033 -0.53 . . . . 1.29 111.49 -179.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.498 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 2.9 p-10 -98.77 126.51 44.42 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.461 -0.336 . . . . 2.25 110.222 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.543 ' HB ' HD13 ' A' ' 34' ' ' ILE . 27.8 m -107.12 33.76 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 116.472 -0.331 . . . . 1.24 111.423 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.0 mtt180 -63.8 -44.5 93.14 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.303 -0.408 . . . . 4.7000000000000002 111.2 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -133.38 50.26 2.23 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.237 -0.438 . . . . 2.4500000000000002 111.454 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.433 ' CG2' HD11 ' A' ' 34' ' ' ILE . 13.1 m -117.66 149.58 19.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.379 -0.373 . . . . 1.3500000000000001 110.692 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.486 ' HB ' ' CB ' ' A' ' 24' ' ' ASP . 0.5 OUTLIER -63.37 160.12 16.73 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.351 -0.386 . . . . 1.6499999999999999 111.558 -178.865 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.617 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 3.2 p-80 -56.83 -33.13 66.45 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 115.901 -0.59 . . . . 2.6899999999999999 110.278 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 39.7 m -74.82 -33.7 62.24 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 116.064 -0.516 . . . . 2.0299999999999998 110.295 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.681 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -67.39 -36.79 82.02 Favored 'General case' 0 CA--C 1.527 0.071 0 N-CA-C 109.777 -0.453 . . . . 1.24 109.777 178.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.613 ' HB1' HD12 ' A' ' 34' ' ' ILE . . . -68.66 -46.6 68.7 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 109.299 -0.63 . . . . 1.0900000000000001 109.299 177.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.502 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 54.0 t -58.15 -50.6 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 115.218 -0.901 . . . . 1.27 109.015 178.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.681 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.19 -30.39 62.21 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.056 -0.975 . . . . 1.49 110.467 178.256 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.611 ' HA ' ' HG2' ' A' ' 79' ' ' GLU . . . -62.12 -47.03 86.4 Favored 'General case' 0 C--N 1.346 0.448 0 N-CA-C 109.57 -0.529 . . . . 1.0700000000000001 109.57 179.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.465 HD21 HD13 ' A' ' 86' ' ' LEU . 2.0 mt -60.37 -35.9 76.77 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.404 -0.816 . . . . 1.3899999999999999 109.858 178.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.602 ' HG2' ' HA ' ' A' ' 75' ' ' GLU . 0.7 OUTLIER -77.28 -27.12 52.97 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.841 -0.618 . . . . 3.6000000000000001 111.268 179.056 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.611 ' HG2' ' HA ' ' A' ' 76' ' ' ALA . 8.3 pt-20 -98.63 13.3 32.56 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.466 -0.334 . . . . 2.5099999999999998 111.382 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.663 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . . . -85.33 16.78 3.45 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.427 -0.351 . . . . 1.1599999999999999 111.44 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.57 -105.21 1.67 Allowed Glycine 0 C--N 1.343 0.968 0 N-CA-C 111.727 -0.549 . . . . 0.87 111.727 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.559 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 20.5 m -128.16 -93.01 0.46 Allowed 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.549 -0.908 . . . . 1.8600000000000001 108.549 178.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.538 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 6.2 tp -80.34 96.37 2.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.282 0.563 . . . . 1.3200000000000001 110.001 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.663 ' CG1' ' HB2' ' A' ' 80' ' ' ALA . 7.2 p -112.2 136.78 47.34 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 N-CA-C 113.137 0.791 . . . . 1.1299999999999999 113.137 -177.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 31.9 mtt180 -85.76 102.23 13.47 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.893 -0.78 . . . . 4.21 108.893 177.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.517 ' CD1' ' HZ ' ' A' ' 17' ' ' PHE . 13.0 mt -91.58 136.56 33.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.926 -0.579 . . . . 1.0700000000000001 111.236 -178.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.522 ' HB3' ' HB2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -100.4 141.68 32.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.351 -0.386 . . . . 2.3500000000000001 110.364 179.686 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.606 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 2.5 m -140.3 168.03 17.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.243 -0.435 . . . . 1.21 111.551 -179.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.468 ' CG ' ' HG ' ' A' ' 58' ' ' LEU . 27.7 mtm -119.48 135.94 54.54 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.07 -0.514 . . . . 2.4100000000000001 110.755 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -140.74 106.91 5.21 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.378 -0.374 . . . . 4.3899999999999997 111.142 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.511 ' HB3' ' HG3' ' A' ' 1' ' ' MET . 0.2 OUTLIER . . . . . 0 C--O 1.251 1.141 0 CA-C-O 118.494 -0.765 . . . . 4.7599999999999998 111.16 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.501 ' HG3' ' HB3' ' A' ' 91' ' ' ARG . 5.7 ttm . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 120.811 0.339 . . . . 3.1099999999999999 111.292 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.8 137.83 32.1 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.082 -0.508 . . . . 2.5299999999999998 110.61 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.484 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 6.3 m-30 -105.74 122.56 46.32 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.472 -0.331 . . . . 1.52 111.025 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -126.94 150.07 49.53 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.26 -0.427 . . . . 2.3900000000000001 111.404 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.03 145.25 30.43 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.109 -0.496 . . . . 2.4500000000000002 110.966 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 1.076 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -133.76 109.15 12.77 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 CA-C-O 120.929 0.395 . . . . 0.84999999999999998 111.388 -179.913 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.929 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -78.26 115.39 17.94 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.092 -0.707 . . . . 0.92000000000000004 109.092 179.065 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.076 HD13 HD11 ' A' ' 6' ' ' ILE . 5.4 tp -126.64 126.11 43.02 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 113.01 0.744 . . . . 0.53000000000000003 113.01 -177.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.585 ' N ' HD12 ' A' ' 83' ' ' ILE . 0.0 OUTLIER -83.02 100.23 10.33 Favored 'General case' 0 CA--C 1.523 -0.083 0 CA-C-N 115.775 -0.648 . . . . 1.96 111.719 179.255 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.568 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -52.37 92.29 0.01 OUTLIER 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.566 -0.743 . . . . 2.2799999999999998 110.546 179.079 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.61 -172.25 3.82 Favored Glycine 0 CA--C 1.52 0.384 0 CA-C-N 115.244 -0.889 . . . . 1.4299999999999999 113.26 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -55.57 -44.91 77.29 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.601 0.239 . . . . 3.1200000000000001 111.151 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 56.3 m -77.45 -25.13 50.29 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.364 -0.38 . . . . 1.8400000000000001 111.406 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 138.56 -157.59 24.66 Favored Glycine 0 C--N 1.338 0.673 0 C-N-CA 120.99 -0.624 . . . . 0.83999999999999997 112.256 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.07 ' HG ' HD23 ' A' ' 8' ' ' LEU . 7.3 tp -67.71 -53.76 24.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.503 0.152 . . . . 1.3600000000000001 110.786 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.506 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 119.4 26.29 2.46 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 120.107 -1.044 . . . . 0.48999999999999999 115.636 177.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.762 ' HB3' HG23 ' A' ' 39' ' ' ILE . 24.8 p90 -164.35 136.29 4.65 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 118.324 1.062 . . . . 1.23 110.992 178.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.3 134.8 40.81 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.999 -0.546 . . . . 0.41999999999999998 111.703 -179.158 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.056 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -117.16 146.32 21.75 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-O 121.699 0.761 . . . . 0.47999999999999998 112.085 179.917 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.779 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -137.8 134.79 35.61 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.34 -1.3 . . . . 0.60999999999999999 111.318 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.455 ' HA2' ' H ' ' A' ' 27' ' ' HIS . . . 145.37 -6.97 1.53 Allowed Glycine 0 CA--C 1.52 0.357 0 C-N-CA 119.908 -1.139 . . . . 1.8 114.294 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.627 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -57.3 178.21 1.0 Allowed Glycine 0 CA--C 1.521 0.466 0 C-N-CA 120.944 -0.646 . . . . 1.4399999999999999 113.97 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.695 HG23 ' O ' ' A' ' 68' ' ' VAL . 19.0 p -60.99 -29.33 69.62 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.037 0.754 . . . . 1.0 113.037 -178.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.486 ' CB ' ' HB ' ' A' ' 69' ' ' THR . 19.3 t70 -87.57 -33.43 18.9 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 111.909 0.337 . . . . 1.8899999999999999 111.909 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -124.52 88.65 53.11 Favored Pre-proline 0 N--CA 1.453 -0.29 0 CA-C-N 116.663 -0.244 . . . . 1.8899999999999999 110.484 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -69.46 73.2 1.25 Allowed 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.662 2.241 . . . . 0.92000000000000004 112.814 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.779 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 8.0 t-80 -52.13 -31.26 30.2 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.529 -0.76 . . . . 1.8100000000000001 110.262 178.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.898 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -79.25 -157.36 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 115.618 -0.719 . . . . 0.76000000000000001 109.965 178.829 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.608 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -62.68 -50.8 60.93 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.752 -0.737 . . . . 1.3899999999999999 112.347 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 177.41 61.32 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.995 0.426 . . . . 2.3500000000000001 110.595 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -148.3 164.61 21.15 Favored Pre-proline 0 C--O 1.234 0.258 0 CA-C-N 116.045 -0.525 . . . . 1.7 111.348 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.652 ' HB3' HG22 ' A' ' 23' ' ' THR . 98.3 Cg_endo -78.85 7.68 4.16 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.755 2.303 . . . . 1.03 113.139 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 68.4 m -61.48 109.8 1.28 Allowed 'General case' 0 C--N 1.341 0.228 0 CA-C-O 120.768 0.318 . . . . 1.1000000000000001 110.412 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.934 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -81.68 118.92 30.27 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.371 0 CA-C-N 115.817 -0.629 . . . . 0.53000000000000003 110.609 -179.485 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.898 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -140.28 148.63 41.71 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-O 121.442 0.639 . . . . 1.3500000000000001 110.948 178.543 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.052 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.55 156.44 7.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 115.428 -0.805 . . . . 0.26000000000000001 113.058 -176.885 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.419 HG21 ' HB2' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -121.35 -33.05 3.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.776 -1.102 . . . . 0.40999999999999998 111.629 -179.541 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.776 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.13 136.17 0.83 Allowed 'General case' 0 C--N 1.338 0.085 0 CA-C-O 120.874 0.369 . . . . 1.45 111.712 -179.832 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.774 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -99.33 130.76 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 108.199 -1.037 . . . . 0.45000000000000001 108.199 177.823 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.428 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 0.0 OUTLIER -83.06 118.81 72.86 Favored Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 112.391 0.515 . . . . 0.55000000000000004 112.391 -177.376 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.541 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 32.3 Cg_exo -58.37 134.69 63.04 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 123.186 2.591 . . . . 0.90000000000000002 112.32 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.37 -5.62 65.27 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 120.895 -0.669 . . . . 0.83999999999999997 112.79 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -95.82 177.28 34.13 Favored Glycine 0 C--N 1.339 0.722 0 C-N-CA 120.823 -0.703 . . . . 0.94999999999999996 111.732 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.768 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -56.19 -37.34 69.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.887 0.343 . . . . 0.72999999999999998 111.303 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.805 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -69.59 -51.69 32.91 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.53 -0.305 . . . . 0.48999999999999999 111.717 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.541 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -67.28 -32.33 73.26 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.272 -0.422 . . . . 0.67000000000000004 111.858 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -73.41 -38.89 65.42 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.715 0.293 . . . . 2.54 110.733 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.43 -58.29 4.18 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.022 -0.536 . . . . 1.8500000000000001 111.043 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.1 35.39 18.34 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.897 -0.592 . . . . 0.64000000000000001 112.588 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.422 ' CB ' HG12 ' A' ' 6' ' ' ILE . 48.1 mtt180 -107.48 -30.24 8.76 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 116.733 0.267 . . . . 2.7599999999999998 110.959 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.052 HD21 HD12 ' A' ' 36' ' ' ILE . 7.3 tp -99.44 155.79 17.37 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.014 0.435 . . . . 0.42999999999999999 111.446 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.558 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.5 OUTLIER -132.15 145.19 51.21 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.577 -0.738 . . . . 3.3900000000000001 110.807 179.947 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.776 HG21 ' HA ' ' A' ' 38' ' ' LYS . 36.1 t -60.96 154.93 4.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 121.083 0.468 . . . . 0.27000000000000002 111.656 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.445 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 1.3 t-20 77.11 1.08 3.11 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.178 -0.919 . . . . 1.3700000000000001 112.07 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.601 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 0.4 OUTLIER -74.88 127.42 33.15 Favored 'General case' 0 C--N 1.338 0.101 0 N-CA-C 109.37 -0.604 . . . . 1.21 109.37 178.889 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.666 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 1.6 t -84.79 102.08 12.75 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 121.611 0.719 . . . . 1.1000000000000001 111.65 -178.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 1.056 HD11 HG21 ' A' ' 19' ' ' ILE . 59.0 mt -45.69 136.49 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 114.593 -1.185 . . . . 0.41999999999999998 112.258 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.55 ' HB2' ' HB3' ' A' ' 87' ' ' TYR . 5.1 mt -112.25 -50.29 2.91 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.301 -0.863 . . . . 1.8899999999999999 110.165 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.518 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 1.7 m-85 -143.45 159.67 41.98 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.775 -0.648 . . . . 1.3400000000000001 111.276 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.825 HG13 HD21 ' A' ' 86' ' ' LEU . 97.5 t -133.86 93.33 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.616 -0.72 . . . . 0.72999999999999998 109.331 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.457 ' CG ' HG23 ' A' ' 84' ' ' VAL . 2.6 t-20 70.98 -68.84 0.2 Allowed 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 109.593 -0.521 . . . . 1.6200000000000001 109.593 -177.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -153.56 31.17 0.46 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.878 -0.601 . . . . 2.6499999999999999 110.117 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.514 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 6.9 t -121.39 135.67 60.79 Favored 'Isoleucine or valine' 0 C--N 1.339 0.113 0 CA-C-N 116.033 -0.53 . . . . 0.63 111.49 -179.267 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.518 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 2.9 p-10 -98.77 126.51 44.42 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.461 -0.336 . . . . 2.25 110.222 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.65 HG21 HG22 ' A' ' 57' ' ' ILE . 27.8 m -107.12 33.76 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 116.472 -0.331 . . . . 0.94999999999999996 111.423 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.0 mtt180 -63.8 -44.5 93.14 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.303 -0.408 . . . . 4.1200000000000001 111.2 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -133.38 50.26 2.23 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.237 -0.438 . . . . 2.4500000000000002 111.454 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.695 ' O ' HG23 ' A' ' 23' ' ' THR . 13.1 m -117.66 149.58 19.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.379 -0.373 . . . . 0.77000000000000002 110.692 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.486 ' HB ' ' CB ' ' A' ' 24' ' ' ASP . 0.5 OUTLIER -63.37 160.12 16.73 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.351 -0.386 . . . . 1.1699999999999999 111.558 -178.865 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.627 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 3.2 p-80 -56.83 -33.13 66.45 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 115.901 -0.59 . . . . 2.1299999999999999 110.278 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 39.7 m -74.82 -33.7 62.24 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 116.064 -0.516 . . . . 1.5700000000000001 110.295 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.697 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -67.39 -36.79 82.02 Favored 'General case' 0 CA--C 1.527 0.071 0 N-CA-C 109.777 -0.453 . . . . 0.65000000000000002 109.777 178.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.934 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -68.66 -46.6 68.7 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 109.299 -0.63 . . . . 0.44 109.299 177.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.653 ' HA ' HD11 ' A' ' 19' ' ' ILE . 54.0 t -58.15 -50.6 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 115.218 -0.901 . . . . 0.67000000000000004 109.015 178.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.697 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.19 -30.39 62.21 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.056 -0.975 . . . . 1.49 110.467 178.256 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.62 ' C ' HG11 ' A' ' 60' ' ' VAL . . . -62.12 -47.03 86.4 Favored 'General case' 0 C--N 1.346 0.448 0 N-CA-C 109.57 -0.529 . . . . 0.37 109.57 179.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 1.043 HD11 HD12 ' A' ' 19' ' ' ILE . 2.0 mt -60.37 -35.9 76.77 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.404 -0.816 . . . . 0.81999999999999995 109.858 178.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.628 ' HG2' ' HA ' ' A' ' 75' ' ' GLU . 0.7 OUTLIER -77.28 -27.12 52.97 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.841 -0.618 . . . . 3.1200000000000001 111.268 179.056 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.609 ' HG2' ' HA ' ' A' ' 76' ' ' ALA . 8.3 pt-20 -98.63 13.3 32.56 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.466 -0.334 . . . . 2.5099999999999998 111.382 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.863 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -85.33 16.78 3.45 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.427 -0.351 . . . . 0.78000000000000003 111.44 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.57 -105.21 1.67 Allowed Glycine 0 C--N 1.343 0.968 0 N-CA-C 111.727 -0.549 . . . . 0.81999999999999995 111.727 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.568 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 20.5 m -128.16 -93.01 0.46 Allowed 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.549 -0.908 . . . . 1.48 108.549 178.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.929 HG13 HG22 ' A' ' 7' ' ' THR . 6.2 tp -80.34 96.37 2.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.282 0.563 . . . . 0.75 110.001 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.863 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 7.2 p -112.2 136.78 47.34 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 N-CA-C 113.137 0.791 . . . . 0.53000000000000003 113.137 -177.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.695 ' HG3' HG23 ' A' ' 7' ' ' THR . 31.9 mtt180 -85.76 102.23 13.47 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.893 -0.78 . . . . 3.75 108.893 177.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.825 HD21 HG13 ' A' ' 60' ' ' VAL . 13.0 mt -91.58 136.56 33.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.926 -0.579 . . . . 0.39000000000000001 111.236 -178.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.55 ' HB3' ' HB2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -100.4 141.68 32.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.351 -0.386 . . . . 1.49 110.364 179.686 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.601 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 2.5 m -140.3 168.03 17.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.243 -0.435 . . . . 0.60999999999999999 111.551 -179.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.468 ' CG ' ' HG ' ' A' ' 58' ' ' LEU . 27.7 mtm -119.48 135.94 54.54 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.07 -0.514 . . . . 1.9199999999999999 110.755 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -140.74 106.91 5.21 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.378 -0.374 . . . . 3.8300000000000001 111.142 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.501 ' HB3' ' HG3' ' A' ' 1' ' ' MET . 0.2 OUTLIER . . . . . 0 C--O 1.251 1.141 0 CA-C-O 118.494 -0.765 . . . . 4.1100000000000003 111.16 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.501 ' HG3' ' HB3' ' A' ' 91' ' ' ARG . 5.7 ttm . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 120.811 0.339 . . . . 3.11 111.292 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.8 137.83 32.1 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.082 -0.508 . . . . 2.53 110.61 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.484 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 6.3 m-30 -105.74 122.56 46.32 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.472 -0.331 . . . . 1.52 111.025 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -126.94 150.07 49.53 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.26 -0.427 . . . . 2.39 111.404 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.03 145.25 30.43 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.109 -0.496 . . . . 2.45 110.966 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 1.076 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -133.76 109.15 12.77 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 CA-C-O 120.929 0.395 . . . . 0.85 111.388 -179.913 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.929 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -78.26 115.39 17.94 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.092 -0.707 . . . . 0.92 109.092 179.065 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.076 HD13 HD11 ' A' ' 6' ' ' ILE . 5.4 tp -126.64 126.11 43.02 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 113.01 0.744 . . . . 0.53 113.01 -177.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.585 ' N ' HD12 ' A' ' 83' ' ' ILE . 0.0 OUTLIER -83.02 100.23 10.33 Favored 'General case' 0 CA--C 1.523 -0.083 0 CA-C-N 115.775 -0.648 . . . . 1.96 111.719 179.255 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.568 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -52.37 92.29 0.01 OUTLIER 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.566 -0.743 . . . . 2.28 110.546 179.079 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.61 -172.25 3.82 Favored Glycine 0 CA--C 1.52 0.384 0 CA-C-N 115.244 -0.889 . . . . 1.43 113.26 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -55.57 -44.91 77.29 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.601 0.239 . . . . 3.12 111.151 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 56.3 m -77.45 -25.13 50.29 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.364 -0.38 . . . . 1.84 111.406 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 138.56 -157.59 24.66 Favored Glycine 0 C--N 1.338 0.673 0 C-N-CA 120.99 -0.624 . . . . 0.84 112.256 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.07 ' HG ' HD23 ' A' ' 8' ' ' LEU . 7.3 tp -67.71 -53.76 24.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.503 0.152 . . . . 1.36 110.786 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.506 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 119.4 26.29 2.46 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 120.107 -1.044 . . . . 0.49 115.636 177.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.762 ' HB3' HG23 ' A' ' 39' ' ' ILE . 24.8 p90 -164.35 136.29 4.65 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 118.324 1.062 . . . . 1.23 110.992 178.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.3 134.8 40.81 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.999 -0.546 . . . . 0.42 111.703 -179.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.056 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -117.16 146.32 21.75 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-O 121.699 0.761 . . . . 0.48 112.085 179.917 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.779 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -137.8 134.79 35.61 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.34 -1.3 . . . . 0.61 111.318 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.455 ' HA2' ' H ' ' A' ' 27' ' ' HIS . . . 145.37 -6.97 1.53 Allowed Glycine 0 CA--C 1.52 0.357 0 C-N-CA 119.908 -1.139 . . . . 1.8 114.294 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.627 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -57.3 178.21 1.0 Allowed Glycine 0 CA--C 1.521 0.466 0 C-N-CA 120.944 -0.646 . . . . 1.44 113.97 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.695 HG23 ' O ' ' A' ' 68' ' ' VAL . 19.0 p -60.99 -29.33 69.62 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.037 0.754 . . . . 1.0 113.037 -178.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.486 ' CB ' ' HB ' ' A' ' 69' ' ' THR . 19.3 t70 -87.57 -33.43 18.9 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 111.909 0.337 . . . . 1.89 111.909 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -124.52 88.65 53.11 Favored Pre-proline 0 N--CA 1.453 -0.29 0 CA-C-N 116.663 -0.244 . . . . 1.89 110.484 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -69.46 73.2 1.25 Allowed 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.662 2.241 . . . . 0.92 112.814 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.779 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 25.7 t60 -52.13 -31.26 30.2 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.529 -0.76 . . . . 1.81 110.262 178.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.898 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -79.25 -157.36 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 115.618 -0.719 . . . . 0.76 109.965 178.829 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.608 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -62.68 -50.8 60.93 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.752 -0.737 . . . . 1.39 112.347 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 177.41 61.32 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.995 0.426 . . . . 2.35 110.595 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -148.3 164.61 21.15 Favored Pre-proline 0 C--O 1.234 0.258 0 CA-C-N 116.045 -0.525 . . . . 1.7 111.348 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.652 ' HB3' HG22 ' A' ' 23' ' ' THR . 98.3 Cg_endo -78.85 7.68 4.16 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.755 2.303 . . . . 1.03 113.139 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 68.4 m -61.48 109.8 1.28 Allowed 'General case' 0 C--N 1.341 0.228 0 CA-C-O 120.768 0.318 . . . . 1.1 110.412 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.934 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -81.68 118.92 30.27 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.371 0 CA-C-N 115.817 -0.629 . . . . 0.53 110.609 -179.485 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.898 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -140.28 148.63 41.71 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-O 121.442 0.639 . . . . 1.35 110.948 178.543 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.052 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.55 156.44 7.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 115.428 -0.805 . . . . 0.26 113.058 -176.885 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.419 HG21 ' HB2' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -121.35 -33.05 3.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.776 -1.102 . . . . 0.41 111.629 -179.541 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.776 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.13 136.17 0.83 Allowed 'General case' 0 C--N 1.338 0.085 0 CA-C-O 120.874 0.369 . . . . 1.45 111.712 -179.832 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.774 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -99.33 130.76 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 108.199 -1.037 . . . . 0.45 108.199 177.823 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.428 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 0.0 OUTLIER -83.06 118.81 72.86 Favored Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 112.391 0.515 . . . . 0.55 112.391 -177.376 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.541 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 32.3 Cg_exo -58.37 134.69 63.04 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 123.186 2.591 . . . . 0.9 112.32 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.37 -5.62 65.27 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 120.895 -0.669 . . . . 0.84 112.79 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -95.82 177.28 34.13 Favored Glycine 0 C--N 1.339 0.722 0 C-N-CA 120.823 -0.703 . . . . 0.95 111.732 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.768 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -56.19 -37.34 69.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.887 0.343 . . . . 0.73 111.303 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.805 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -69.59 -51.69 32.91 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.53 -0.305 . . . . 0.49 111.717 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.541 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -67.28 -32.33 73.26 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.272 -0.422 . . . . 0.67 111.858 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -73.41 -38.89 65.42 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.715 0.293 . . . . 2.54 110.733 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.43 -58.29 4.18 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.022 -0.536 . . . . 1.85 111.043 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.1 35.39 18.34 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.897 -0.592 . . . . 0.64 112.588 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.422 ' CB ' HG12 ' A' ' 6' ' ' ILE . 48.1 mtt180 -107.48 -30.24 8.76 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 116.733 0.267 . . . . 2.76 110.959 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.052 HD21 HD12 ' A' ' 36' ' ' ILE . 7.3 tp -99.44 155.79 17.37 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.014 0.435 . . . . 0.43 111.446 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.558 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.5 OUTLIER -132.15 145.19 51.21 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.577 -0.738 . . . . 3.39 110.807 179.947 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.776 HG21 ' HA ' ' A' ' 38' ' ' LYS . 36.1 t -60.96 154.93 4.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 121.083 0.468 . . . . 0.27 111.656 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.445 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 1.3 t-20 77.11 1.08 3.11 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.178 -0.919 . . . . 1.37 112.07 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.601 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 0.4 OUTLIER -74.88 127.42 33.15 Favored 'General case' 0 C--N 1.338 0.101 0 N-CA-C 109.37 -0.604 . . . . 1.21 109.37 178.889 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.666 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 1.6 t -84.79 102.08 12.75 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 121.611 0.719 . . . . 1.1 111.65 -178.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 1.056 HD11 HG21 ' A' ' 19' ' ' ILE . 59.0 mt -45.69 136.49 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 114.593 -1.185 . . . . 0.42 112.258 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.55 ' HB2' ' HB3' ' A' ' 87' ' ' TYR . 5.1 mt -112.25 -50.29 2.91 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.301 -0.863 . . . . 1.89 110.165 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.518 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 1.7 m-85 -143.45 159.67 41.98 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.775 -0.648 . . . . 1.34 111.276 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.825 HG13 HD21 ' A' ' 86' ' ' LEU . 97.5 t -133.86 93.33 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.616 -0.72 . . . . 0.73 109.331 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.457 ' CG ' HG23 ' A' ' 84' ' ' VAL . 2.6 t-20 70.98 -68.84 0.2 Allowed 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 109.593 -0.521 . . . . 1.62 109.593 -177.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -153.56 31.17 0.46 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.878 -0.601 . . . . 2.65 110.117 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.514 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 6.9 t -121.39 135.67 60.79 Favored 'Isoleucine or valine' 0 C--N 1.339 0.113 0 CA-C-N 116.033 -0.53 . . . . 0.63 111.49 -179.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.518 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 2.9 p-10 -98.77 126.51 44.42 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.461 -0.336 . . . . 2.25 110.222 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.65 HG21 HG22 ' A' ' 57' ' ' ILE . 27.8 m -107.12 33.76 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 116.472 -0.331 . . . . 0.95 111.423 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.0 mtt180 -63.8 -44.5 93.14 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.303 -0.408 . . . . 4.12 111.2 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -133.38 50.26 2.23 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.237 -0.438 . . . . 2.45 111.454 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.695 ' O ' HG23 ' A' ' 23' ' ' THR . 13.1 m -117.66 149.58 19.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.379 -0.373 . . . . 0.77 110.692 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.486 ' HB ' ' CB ' ' A' ' 24' ' ' ASP . 0.5 OUTLIER -63.37 160.12 16.73 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.351 -0.386 . . . . 1.17 111.558 -178.865 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.627 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 3.2 p-80 -56.83 -33.13 66.45 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 115.901 -0.59 . . . . 2.13 110.278 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 39.7 m -74.82 -33.7 62.24 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 116.064 -0.516 . . . . 1.57 110.295 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.697 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -67.39 -36.79 82.02 Favored 'General case' 0 CA--C 1.527 0.071 0 N-CA-C 109.777 -0.453 . . . . 0.65 109.777 178.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.934 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -68.66 -46.6 68.7 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 109.299 -0.63 . . . . 0.44 109.299 177.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.653 ' HA ' HD11 ' A' ' 19' ' ' ILE . 54.0 t -58.15 -50.6 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 115.218 -0.901 . . . . 0.67 109.015 178.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.697 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.19 -30.39 62.21 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.056 -0.975 . . . . 1.49 110.467 178.256 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.62 ' C ' HG11 ' A' ' 60' ' ' VAL . . . -62.12 -47.03 86.4 Favored 'General case' 0 C--N 1.346 0.448 0 N-CA-C 109.57 -0.529 . . . . 0.37 109.57 179.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 1.043 HD11 HD12 ' A' ' 19' ' ' ILE . 2.0 mt -60.37 -35.9 76.77 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.404 -0.816 . . . . 0.82 109.858 178.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.628 ' HG2' ' HA ' ' A' ' 75' ' ' GLU . 0.7 OUTLIER -77.28 -27.12 52.97 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.841 -0.618 . . . . 3.12 111.268 179.056 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.609 ' HG2' ' HA ' ' A' ' 76' ' ' ALA . 8.3 pt-20 -98.63 13.3 32.56 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.466 -0.334 . . . . 2.51 111.382 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.863 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -85.33 16.78 3.45 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.427 -0.351 . . . . 0.78 111.44 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.57 -105.21 1.67 Allowed Glycine 0 C--N 1.343 0.968 0 N-CA-C 111.727 -0.549 . . . . 0.82 111.727 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.568 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 20.5 m -128.16 -93.01 0.46 Allowed 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.549 -0.908 . . . . 1.48 108.549 178.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.929 HG13 HG22 ' A' ' 7' ' ' THR . 6.2 tp -80.34 96.37 2.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.282 0.563 . . . . 0.75 110.001 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.863 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 7.2 p -112.2 136.78 47.34 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 N-CA-C 113.137 0.791 . . . . 0.53 113.137 -177.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.695 ' HG3' HG23 ' A' ' 7' ' ' THR . 31.9 mtt180 -85.76 102.23 13.47 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.893 -0.78 . . . . 3.75 108.893 177.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.825 HD21 HG13 ' A' ' 60' ' ' VAL . 13.0 mt -91.58 136.56 33.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.926 -0.579 . . . . 0.39 111.236 -178.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.55 ' HB3' ' HB2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -100.4 141.68 32.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.351 -0.386 . . . . 1.49 110.364 179.686 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.601 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 2.5 m -140.3 168.03 17.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.243 -0.435 . . . . 0.61 111.551 -179.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.468 ' CG ' ' HG ' ' A' ' 58' ' ' LEU . 27.7 mtm -119.48 135.94 54.54 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.07 -0.514 . . . . 1.92 110.755 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -140.74 106.91 5.21 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.378 -0.374 . . . . 3.83 111.142 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.501 ' HB3' ' HG3' ' A' ' 1' ' ' MET . 0.2 OUTLIER . . . . . 0 C--O 1.251 1.141 0 CA-C-O 118.494 -0.765 . . . . 4.11 111.16 179.805 . . . . . . . . 2 2 . 1 stop_ save_